Infectious Diseases Consultation Servives in combination with Antibiotic Stewardship Activities in German Non-University Hospitals

Infectious Diseases Consultation Servives in combination with Antibiotic Stewardship Activities in German Non-University Hospitals - ID-ROLL-OUT

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00023710

Enrollment

903

Registered

2021-04-09

Start date

2021-04-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

staphylococcus aureus bacteremia community-acquired pneumonia

Interventions

Group 1: Antibiotic Stewardship (ABS) activities in combination with infectiological consulting (ABS+IB): - Establishment of local therapy guidelines including perioperative prophylaxis, anti-infectiv

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: one of the two indicator diseases (S. aureus bacteremia [SAB], outpatient acquired pneumonia [CAP])

Exclusion criteria

Exclusion criteria: Existence of incomplete data regarding indicator diseases. Regarding CAP: no new/admitted infiltrate, younger 18 years, neutropenia (20mg prednisone equivalent), recent organ transplant, recent autologous/allogeneic stem cell transplant, HIV infection (viral load>20Cop/ml), symptom onset >48 hours after hospitalisation, hospitalisation within 30 days prior to presentation to physician, pneumonia diagnosis >48 hours after endotracheal intubation, COVID-19 infection, patient in psychiatric care. Regarding SAB: younger 18 years, proven s.aureus bacteraemia, patient in psychiatric care, palliative therapy concept, deceased within 48 hours after hospitalisation.

Design outcomes

Primary

Measure	Time frame
Infectiological quality of care as well as antibiotic prescription quality and density of prescriptions were assessed as SAB-Score (5 items, 1 point each) and CAP-Score (4 items, 1 point each)	—

Secondary

Measure	Time frame
Patient-related: hospital mortality, length of hospital stay, readmission within 4 weeks, C. difficile incidence, anti-infective costs, microbiological/virological diagnostic costs; hospital-related: Antibiotics prescription quality and density, total cost calculation	—

Countries

Germany

Contacts

Public ContactSiegbert Rieg

Abteilung InfektiologieKlinik für Innere Medizin IIDepartment Innere MedizinUniversitätsklinikum Freiburg

siegbert.rieg@uniklinik-freiburg.de0761/270-18240

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 14, 2026